1. Home
  2. PROF vs DHY Comparison

PROF vs DHY Comparison

Compare PROF & DHY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PROF
  • DHY
  • Stock Information
  • Founded
  • PROF N/A
  • DHY 1998
  • Country
  • PROF Canada
  • DHY United States
  • Employees
  • PROF N/A
  • DHY N/A
  • Industry
  • PROF Medical/Dental Instruments
  • DHY Finance/Investors Services
  • Sector
  • PROF Health Care
  • DHY Finance
  • Exchange
  • PROF Nasdaq
  • DHY Nasdaq
  • Market Cap
  • PROF 186.3M
  • DHY 221.5M
  • IPO Year
  • PROF N/A
  • DHY N/A
  • Fundamental
  • Price
  • PROF $7.55
  • DHY $2.23
  • Analyst Decision
  • PROF Strong Buy
  • DHY
  • Analyst Count
  • PROF 2
  • DHY 0
  • Target Price
  • PROF $11.40
  • DHY N/A
  • AVG Volume (30 Days)
  • PROF 45.3K
  • DHY 569.1K
  • Earning Date
  • PROF 11-07-2024
  • DHY 01-01-0001
  • Dividend Yield
  • PROF N/A
  • DHY 9.10%
  • EPS Growth
  • PROF N/A
  • DHY N/A
  • EPS
  • PROF N/A
  • DHY N/A
  • Revenue
  • PROF $8,984,000.00
  • DHY N/A
  • Revenue This Year
  • PROF $56.11
  • DHY N/A
  • Revenue Next Year
  • PROF $171.96
  • DHY N/A
  • P/E Ratio
  • PROF N/A
  • DHY N/A
  • Revenue Growth
  • PROF 39.35
  • DHY N/A
  • 52 Week Low
  • PROF $7.11
  • DHY $1.77
  • 52 Week High
  • PROF $11.42
  • DHY $2.08
  • Technical
  • Relative Strength Index (RSI)
  • PROF 44.16
  • DHY 62.45
  • Support Level
  • PROF $7.40
  • DHY $2.13
  • Resistance Level
  • PROF $8.22
  • DHY $2.17
  • Average True Range (ATR)
  • PROF 0.50
  • DHY 0.02
  • MACD
  • PROF -0.06
  • DHY 0.01
  • Stochastic Oscillator
  • PROF 8.32
  • DHY 95.00

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About DHY Credit Suisse High Yield Bond Fund

Credit Suisse High Yield Bond Fund is a non-diversified, closed-end management investment company with the objective to seek high current income and capital appreciation as a secondary objective.

Share on Social Networks: